Focused Alpha LLC’s Sanofi SNY Stock Holding History

Focused Alpha LLC’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$264K	Buy	5,489 +1,198	+28%	+$55.9K	0.08%	227
2025 Q4	$208K	Buy	+4,291	New	+$213K	0.06%	235

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Focused Alpha LLC's SNY Position: Q1 2026 in Review

Focused Alpha LLC increased its Sanofi (SNY) stake by 28% in Q1 2026, buying an estimated $55.9K and bringing the position to 5,489 shares worth $264K. The position accounts for 0.08% of the portfolio, ranked #227.

Focused Alpha LLC first reported a position in SNY in Q4 2025 and has held it in 2 quarters since. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

Focused Alpha LLC held 5,489 shares of Sanofi worth $264K as of Q1 2026.
Focused Alpha LLC bought 1,198 Sanofi shares in Q1 2026, an estimated $55.9K.
Sanofi made up 0.08% of Focused Alpha LLC's portfolio in Q1 2026, its #227 holding.
Focused Alpha LLC first reported a position in Sanofi in Q4 2025 and has held it in 2 quarters since.
737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Focused Alpha LLC's 13F filing for Q1 2026, filed 12 May 2026.